Home >> Healthcare >> Sodium Iodide 131I Diagnostic Capsules Market

Global Sodium Iodide (131I) Diagnostic Capsules Market Size,Trends, Growth Forecast to 2031

Category : Healthcare | Report Code : 946 | Pages : 141 | Oct 2024

Report Overview

Sodium iodide (131I) diagnostic capsule is a radioactive drug used for the diagnosis of thyroid disease-related diseases. Iodine-131 (131I, I-131) is an important radioisotope of iodine discovered by Glenn Seaborg and John Livingood in 1938 at the University of California, Berkeley. It has a radioactive decay half-life of about eight days. It is associated with nuclear energy, medical diagnostic and treatment procedures, and natural gas production.

The global Sodium Iodide (131I) Diagnostic Capsules market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

Analytic Insights Hub ' newest research report, the “Sodium Iodide (131I) Diagnostic Capsules Industry Forecast” looks at past sales and reviews total world Sodium Iodide (131I) Diagnostic Capsules sales in 2023, providing a comprehensive analysis by region and market sector of projected Sodium Iodide (131I) Diagnostic Capsules sales for 2024 through 2030. With Sodium Iodide (131I) Diagnostic Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sodium Iodide (131I) Diagnostic Capsules industry.

This Insight Report provides a comprehensive analysis of the global Sodium Iodide (131I) Diagnostic Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sodium Iodide (131I) Diagnostic Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sodium Iodide (131I) Diagnostic Capsules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sodium Iodide (131I) Diagnostic Capsules and breaks down the forecast by Specification, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sodium Iodide (131I) Diagnostic Capsules.

United States market for Sodium Iodide (131I) Diagnostic Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Sodium Iodide (131I) Diagnostic Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Sodium Iodide (131I) Diagnostic Capsules is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Sodium Iodide (131I) Diagnostic Capsules players cover Jubilant Radiopharma, Beijing Atom High-Tech, Curium Pharma, NTP Radioisotopes, PDRadiopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Iodide (131I) Diagnostic Capsules market by product type, application, key manufacturers and key regions and countries.

Segmentation by Specification:
    0.333MBq
    3.7MBq
    Others

Segmentation by Application:
    Hyperthyroidism
    Thyroid Cancer

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Jubilant Radiopharma
    Beijing Atom High-Tech
    Curium Pharma
    NTP Radioisotopes
    PDRadiopharma

Key Questions Addressed in this Report
What is the 10-year outlook for the global Sodium Iodide (131I) Diagnostic Capsules market?
What factors are driving Sodium Iodide (131I) Diagnostic Capsules market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sodium Iodide (131I) Diagnostic Capsules market opportunities vary by end market size?
How does Sodium Iodide (131I) Diagnostic Capsules break out by Specification, by Application?

Frequently Asked Questions?

Ans - The purpose of a Sodium Iodide (131I) Diagnostic Capsules market research report is to provide data-driven insights and analysis on a Sodium Iodide (131I) Diagnostic Capsules market. It helps businesses understand industry trends, competition, consumer behavior, market size, growth potential, and risks, supporting strategic decision-making.

Ans - Market research reports typically include both quantitative (market size, revenue, growth rates) and qualitative (trends, consumer preferences, competitive analysis) data. It often includes industry statistics, surveys, expert opinions, historical data, and future forecasts.

Ans - The forecast period typically for Sodium Iodide (131I) Diagnostic Capsules market report spans the next 5 to 10 years. It includes projected market trends, growth opportunities, and potential challenges.

Ans - Yes, Analytic Insights Hub customization services, allowing businesses to focus on specific geographies, sectors, or market segments that are relevant to them.

Ans - The report highlights major trends such as technological innovations, consumer behavior shifts, regulatory changes, or emerging markets that may impact the industry?s growth.